The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It’s the same drug that was linked to last year’s deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
Was this article valuable?
Here are more articles you may enjoy.
Private Equity-Backed Insurance Broker Hub International Files Confidentially for IPO 
California and US West Threatened by Wildfires Over Coming Days 
London Faces Huge Financial Cost Tied to Rising Heat, Mayor Says 
Ex-NFL Player’s Parents Allege Excessive Police Force Led to His Wrongful Death 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.